No.2 antiphlogistic and anti-neoplastic powder

No.2 antiphlogistic and anti-neoplastic powder

The No.2 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 87.5% and curative rate o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU GUOLIANG, LIU GUOPEI, LIU XINSHI
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIU GUOLIANG
LIU GUOPEI
LIU XINSHI
description The No.2 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 87.5% and curative rate of 10.5% to cancers of esphagus, cardia, liver, lung and stomach.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1111132A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1111132A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1111132A3</originalsourceid><addsrcrecordid>eNrjZNDzy9czUkjMK8ksyMjJT88sLslMBnJTwEK6ean5BTmJYLGC_PKU1CIeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GcIAsZGjsaEVQAAOKEpcw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>No.2 antiphlogistic and anti-neoplastic powder</title><source>esp@cenet</source><creator>LIU GUOLIANG ; LIU GUOPEI ; LIU XINSHI</creator><creatorcontrib>LIU GUOLIANG ; LIU GUOPEI ; LIU XINSHI</creatorcontrib><description>The No.2 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 87.5% and curative rate of 10.5% to cancers of esphagus, cardia, liver, lung and stomach.</description><edition>5</edition><language>eng</language><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951108&amp;DB=EPODOC&amp;CC=CN&amp;NR=1111132A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951108&amp;DB=EPODOC&amp;CC=CN&amp;NR=1111132A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU GUOLIANG</creatorcontrib><creatorcontrib>LIU GUOPEI</creatorcontrib><creatorcontrib>LIU XINSHI</creatorcontrib><title>No.2 antiphlogistic and anti-neoplastic powder</title><description>The No.2 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 87.5% and curative rate of 10.5% to cancers of esphagus, cardia, liver, lung and stomach.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDzy9czUkjMK8ksyMjJT88sLslMBnJTwEK6ean5BTmJYLGC_PKU1CIeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GcIAsZGjsaEVQAAOKEpcw</recordid><startdate>19951108</startdate><enddate>19951108</enddate><creator>LIU GUOLIANG</creator><creator>LIU GUOPEI</creator><creator>LIU XINSHI</creator><scope>EVB</scope></search><sort><creationdate>19951108</creationdate><title>No.2 antiphlogistic and anti-neoplastic powder</title><author>LIU GUOLIANG ; LIU GUOPEI ; LIU XINSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1111132A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><toplevel>online_resources</toplevel><creatorcontrib>LIU GUOLIANG</creatorcontrib><creatorcontrib>LIU GUOPEI</creatorcontrib><creatorcontrib>LIU XINSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU GUOLIANG</au><au>LIU GUOPEI</au><au>LIU XINSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>No.2 antiphlogistic and anti-neoplastic powder</title><date>1995-11-08</date><risdate>1995</risdate><abstract>The No.2 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 87.5% and curative rate of 10.5% to cancers of esphagus, cardia, liver, lung and stomach.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN1111132A
source esp@cenet
title No.2 antiphlogistic and anti-neoplastic powder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T11%3A46%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU%20GUOLIANG&rft.date=1995-11-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1111132A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true